Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

Germany's biologics market, the largest in Europe, is expected to grow at a 3.8% CAGR from 2025 to 2035. AI is driving this growth by enhancing R&D, optimizing drug design, and identifying novel ...

Scientists have created the first single cell genomic atlas of mature plants' outer armor layer, called the periderm, and its carbon-capturing phellem cells. The findings will be useful in creating ...

The Structural and Functional Diversity of Peptides Studies suggest that peptides may exhibit remarkable diversity in structure and function, which arises from variations in amino acid composition, ...

Scientists at Cambridge have unveiled a fascinating mechanism where fetuses use a paternal gene to control the mother's ...

This breakthrough finding revealed a long-postulated ... Noninvasive Measurement of Gene Expression at Target Locations in the Brain Aug. 7, 2024 — Bioengineers have developed a noninvasive tool ...

Loss of the Y chromosome (LOY) in men, a dynamic mutation linked to aging, impairs immune function and increases risks of ...

New research shows that not all brain cells age equally, with certain cells, such as those in the hypothalamus, experiencing ...

This important study reveals a critical role of the transcription factor NR2F2 in mouse fetal Leydig cell (FLC) differentiation. With elegantly carried out experiments, the authors provide compelling ...

Entire industries have been built upon the criticism and attempted reduction of body fat. But fat, formally known as adipose tissue, is a crucial part of your hormonal and metabolic processes. Adipose ...

Factors like genetic recombination, environmental influences, and even recessive traits passed down through generations play ...

Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Chronic Lymphocytic Leukemia (CLL).